Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022;62(2):79-84.
doi: 10.3960/jslrt.22011.

Idiopathic plasmacytic lymphadenopathy: A conceptual history along with a translation of the original Japanese article published in 1980

Affiliations

Idiopathic plasmacytic lymphadenopathy: A conceptual history along with a translation of the original Japanese article published in 1980

Kengo Takeuchi. J Clin Exp Hematop. 2022.

Abstract

The current consensus on Castleman disease is that it is a group of several distinct lymphoproliferative disorders with different underlying pathogenesis and clinical outcomes. In 1980, Mori et al. proposed the concept of idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia (IPL), a disease of unknown etiology, characterized by severe polyclonal hypergammaglobulinemia and generalized superficial lymphadenopathy. After Frizzera et al.'s landmark report in 1983, the term multicentric Castleman disease (MCD) gradually became established, and for a time, IPL was regarded as identical to MCD. However, with the subsequent recognition of human herpesvirus 8 (HHV8)-related MCD in the 1990s and the contributions by Kojima et al. in the 2000s, in which non-HHV8-related MCD (now called idiopathic MCD) was at least subclassified into IPL and others (non-IPL), it is now clear that the original distinctiveness of IPL is still maintained in MCD, which is a diverse collection of diseases.

Keywords: IPL; MCD; TAFRO syndrome; iMCD; idiopathic plasmacytic lymphadenopathy.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors have no conflicts of interest directly relevant to the content of this article.

Figures

Fig. 1
Fig. 1
Evolution of the concept of Castleman disease
Fig. 2
Fig. 2
Histopathology of Castleman disease, hyaline vascular-subtype Branched vessels with focal hyalinization are observed in the follicle. In this follicle, several regressive germinal centers are grouped by fusion of the thick mantle zones, in which small lymphocytes are concentrically arranged.
Fig. 3
Fig. 3
Histopathology of Castleman disease, plasma cell-subtype The germinal center is well-demarcated from the mantle zone and does not harbor highly branched and hyalinized vessels, clearly different from the vascular changes in the germinal centers of Castleman disease, hyaline vascular-subtype. The mantle zone constitutes concentrically arranged small lymphocytes but is not very thick. Plasmacytosis is observed immediately adjacent to the mantle zone, associated with vascular proliferation.

Similar articles

Cited by

References

    1. Wu D, Lim MS, Jaffe ES. Pathology of Castleman Disease. Hematol Oncol Clin North Am. 2018; 32: 37-52. - PubMed
    1. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972; 29: 670-683. - PubMed
    1. Flendrig J. Benign giant lymphoma: Clinicopathologic correlation study. In: Clark R, Gumley R (eds): The Year Book of Cancer. Chicago, Year Book Medical Publishers. 1970; pp. 296-299.
    1. Case 40011. N Engl J Med. 1954; 250: 26-30. - PubMed
    1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer. 1956; 9: 822-830. - PubMed

Supplementary concepts